Bombardier Unveils Bold New Brand Identity Worldwide as Company Soars Toward an Ambitious Future
Globe Newswire25-04-2024, 04:12
Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment Following First-line Therapy Met Primary Endpoint 12-04-2023, 10:47